1,050
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Microenvironment-associated lymph node metastasis of human cervical carcinoma xenografts

, , &
Pages 465-472 | Received 28 Jun 2011, Accepted 19 Oct 2011, Published online: 31 Jan 2012

Abstract

Background. The prognosis is particularly poor for patients with advanced squamous cell carcinoma of the uterine cervix when the primary tumor has developed severe physiological abnormalities. The impact of the physiological microenvironment of the primary tumor on lymph node metastasis was investigated in this preclinical study. Material and methods. Xenografted tumors of two human cervical carcinoma lines (CK-160 and TS-415) transplanted into BALB/c nu/nu mice were included in the study. The fraction of radiobiologically hypoxic cells (HFRad), interstitial fluid pressure (IFP), and extracellular pH (pHe) were measured in 22 CK-160 tumors and 16 TS-415 tumors and related to the metastatic status of the host mice. Results. In CK-160, HFRad was significantly higher in the metastatic than in the nonmetastatic tumors, whereas the metastatic and nonmetastatic tumors did not differ significantly in IFP or pHe. In TS-415, IFP was significantly higher in the tumors that metastasized than in those that did not metastasize, whereas the tumors of the metastasis-positive and metastasis-negative mice did not differ significantly in HFRad or pHe. Conclusion. Lymph node metastasis is associated with abnormalities in the physiological microenvironment of the primary tumor in cervical carcinoma xenografts, and tumor line-specific mechanisms are probably involved.

Advanced squamous cell carcinoma of the uterine cervix is treated with radiation therapy alone or radiation therapy in combination with surgery and/or chemotherapy [Citation1]. Important clinical prognostic factors include stage of disease, tumor volume, and lymph node status [Citation2]. The outcome of treatment varies significantly among individual patients of the same prognostic group, and it has been suggested that this variability is a consequence of differences in the physiological microenvironment of the primary tumor [Citation3].

Primary tumors may develop an irregular microvascular network during growth, resulting in inadequate blood supply and an abnormal physiological microenvironment [Citation4]. Abnormalities in the physiological microenvironment have been demonstrated in a wide variety of human tumors, including soft tissue sarcomas, prostate adenocarcinomas, colorectal carcinomas, carcinomas of the head and neck, and cervical carcinomas [3 − 5]. The physiological microenvironment of cervical carcinomas is characterized by low oxygen tension (pO2), regions with hypoxic tissue (pO2 < 10 mmHg), elevated interstitial fluid pressure (IFP), low extracellular pH (pHe), and high lactate concentration [Citation6–8]. This microenvironment may cause resistance to treatment and promote invasive growth and metastatic dissemination [Citation9–11]. Thus, extensive hypoxia in the primary tumor has been shown to be associated with locoregional treatment failure and poor disease-free and overall survival rates in advanced cervical carcinoma [Citation12–15], and studies of cervical cancer patients treated with radiation therapy alone have shown that high IFP in the primary tumor is linked to high probability of pelvic recurrence and distant metastases [Citation16,Citation17]. Moreover, the disease-free and overall survival rates have been shown to be particularly poor for cervical cancer patients with high lactate concentration in the primary tumor [Citation18].

A single pathophysiological parameter was studied in most of these investigations. However, Fyles et al. [Citation16] measured both IFP and pO2 in the primary tumor of more than 100 patients with advanced cervical carcinoma, and this study showed no significant correlation between IFP and hypoxic fraction or between either IFP and hypoxic fraction and clinical prognostic factors, such as stage, tumor size, hemoglobin concentration, and histological grade. Moreover, the independent prognostic effect of IFP for recurrence and survival was strong, whereas the independent prognostic effect of hypoxia was of borderline significance and was limited to patients without nodal metastases [Citation16]. Except for this study, little information is available on the relationship between the various parameters of the physiological microenvironment of cervical carcinomas and their relative impact on radiocurability and metastatic spread.

In the present investigation, we studied the impact of the physiological microenvironment of the primary tumor on lymph node metastasis in cervical carcinoma xenografts. Three pathophysiological parameters (i.e. hypoxic fraction, IFP, and pHe) were measured in each tumor and related to the metastatic status of the host mouse. Xenografted tumors of two cervical carcinoma lines differing in histological appearance were included in the study.

Material and methods

Tumor models

CK-160 and TS-415 cervical carcinoma xenografts growing in the gastrocnemius muscle of adult female BALB/c nu/nu mice were used as tumor models [Citation19]. Tumors were initiated from established cell lines cultured in RPMI-1640 (25 mmol/l HEPES and l-glutamine) medium supplemented with 13% bovine calf serum, 250 mg/l penicillin, and 50 mg/l streptomycin. The cell lines were established in our laboratory from patients admitted to the Norwegian Radium Hospital for the treatment of FIGO stage IIB squamous cell carcinoma of the uterine cervix. The CK-160 line was derived from a pelvic lymph node metastasis of a 65-year-old woman having developed a well-differentiated keratinizing primary tumor. The tumor responded well to radiation therapy, but was highly metastatic. The TS-415 line was derived from a pelvic lymph node metastasis of a 45-year-old woman having developed a poorly differentiated nonkeratinizing primary tumor. The tumor was moderately metastatic, but resistant to radiation treatment. Comparative studies have shown that the histology of CK-160 and TS-415 xenografts is similar to that of the donor patients’ tumors [Citation19], and this was confirmed in the present study. Thus, the CK-160 xenografts showed well-differentiated keratinizing cells consistent with Grade I squamous cell carcinoma of the uterine cervix (a), whereas the TS-415 xenografts were poorly differentiated with a histological appearance consistent with Grade III squamous cell cervical carcinoma (b).

Figure 1. Histological preparations of a well-differentiated CK-160 (a) and a poorly differentiated TS-415 (b) tumor stained with hematoxylin and eosin.

Figure 1. Histological preparations of a well-differentiated CK-160 (a) and a poorly differentiated TS-415 (b) tumor stained with hematoxylin and eosin.

Anesthesia and animal care

Tumor irradiation and measurement of IFP and pHe were carried out with anesthetized mice (0.63 mg/kg of fentanyl citrate, 20 mg/kg of fluanisone, and 10 mg/kg of midazolam) when the tumors had grown to a volume of ∼400 mm3. Animal care and experimental procedures were approved by the Institutional Committee on Research Animal Care and were performed in accordance with the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Marketing, and Education (New York Academy of Sciences, New York, NY, USA).

IFP

IFP was measured in the center of the tumors by using a Millar SPC 320 catheter equipped with a 2F Mikro-Tip tranceducer with diameter 0.66 mm (Millar Instruments, Houston, TX, USA) [Citation20]. The catheter was connected to a computer via a Millar TC-510 control unit and a model 13-66150-50 preamplifier (Gould Instruments, Cleveland, OH, USA). Data acquisition was carried out by using LabVIEW software (National Instruments, Austin, TX, USA).

pHe

An MI-407B needle electrode (Microelectrodes, Bedford, NH, USA) connected to a millivolt adaptor (MV-ADPT) was used to measure pHe. A reference electrode (MI-402; Microelectrodes) was placed subcutaneously in the tumor-bearing leg. The electrodes were calibrated by using calibration buffers with pH values of 5.0, 6.0, and 7.0. A measurement lasted 12–20 min and was accepted only when the pHe readings during the last 3 min did not change by more than 0.005 pH units/min [Citation19]. LabVIEW software was used for data acquisition.

Irradiation

Tumors were irradiated under air-breathing or hypoxic conditions at a dose rate of 5.1 Gy/min by using an x-ray therapy unit operated at 220 kV, 19 to 20 mA, and with 0.5-mm Cu filtration [Citation21]. Hypoxic tumors were obtained by euthanizing the host mice 5 min before the radiation exposure.

Cell survival assay

The cell survival of irradiated tumors was measured in vitro [Citation22]. Briefly, the tumors were resected immediately after the radiation exposure, minced in cold saline, and treated with an enzyme solution (0.2% collagenase, 0.05% Pronase, and 0.02% DNase) at 37°C for 2 h. Trypan blue-negative cells were plated in 25-cm2 tissue culture flasks and incubated at 37°C for 14 days for colony formation. Cell surviving fractions were calculated from the number of colonies counted and the number of cells seeded, corrected for the mean plating efficiency of the cells of six untreated control tumors.

Fraction of radiobiologically hypoxic cells

The fraction of radiobiologically hypoxic cells in a tumor was measured by using a procedure based on the paired survival curve method [Citation21]. The tumor was irradiated with 10 Gy under air-breathing conditions, and the fraction of surviving tumor cells [SF10 (air-breathing)] was determined as described above. The fraction of radiobiologically hypoxic cells (HFRad) was calculated as HFRad = SF10 (air-breathing)/SF10 (hypoxic), where SF10 (hypoxic) represents the mean cell surviving fraction of 10 tumors irradiated with 10 Gy under hypoxic conditions. A radiation dose of 10 Gy was chosen for assessment of HFRad because the fraction of normoxic tumor cells surviving exposure to 10 Gy has been shown to be insignificant in CK-160 and TS-415 xenografts [Citation19,Citation23]. The assessment of HFRad in individual tumors from measurements of SF10 has been justified previously [Citation21]. The theoretical basis for the paired survival curve method has been described in detail by Hall in his textbook on basic radiation biology [Citation24].

Metastasis

Metastatic status was assessed as described elsewhere [Citation19]. Briefly, euthanized mice were examined for external lymph node metastases in the inguinal, axillary, interscapular, and submandibular regions and internal lymph node metastases in the abdomen and mediastinum. The presence of metastatic growth in enlarged lymph nodes was confirmed by histological examination.

Statistical analysis

Data are presented as arithmetic mean ± SE unless otherwise stated. The Pearson product moment correlation test was used to search for correlations between parameters. Statistical comparisons of data were carried out by using the Student's t-test when the data complied with the conditions of normality and equal variance. Under other conditions, comparisons were carried out by nonparametric analysis using the Mann-Whitney rank-sum test. Probability values of p < 0.05, determined from two-sided tests, were considered significant. The statistical analysis was performed by using the SigmaStat statistical software (SPSS Science, Chicago, IL, USA).

Results

HFRad, IFP, and pHe were measured in 22 CK-160 and 16 TS-415 tumors and related to the metastatic status of the host mice. After exposure to 10 Gy under air-breathing conditions, the tumors showed cell surviving fractions differing by factors of ∼3.5 (CK-160) and ∼4.8 (TS-415), whereas the cell surviving fractions of the 10 tumors exposed to 10 Gy under hypoxic conditions differed by a factor of ∼1.1 in both lines (). The mean values of SF10 (air-breathing) and SF10 (hypoxic) were 0.019 and 0.044, respectively, for the CK-160 tumors and 0.043 and 0.18, respectively, for the TS-415 tumors. The coefficients of variation were 34% [SF10 (air-breathing)] and 2.6% [SF10 (hypoxic)] for the CK-160 tumors and 43% [SF10 (air-breathing)] and 4.5% [SF10 (hypoxic)] for the TS-415 tumors. The differences in SF10 (air-breathing) among the 22 CK-160 tumors and the differences in SF10 (air-breathing) among the 16 TS-415 tumors thus reflected primarily differences in the extent of hypoxia and not experimental uncertainty.

Figure 2. Cell surviving fractions of CK-160 and TS-415 tumors irradiated with 10 Gy under air-breathing (○) or hypoxic (•) conditions. Points and horizontal lines represent individual tumors and mean values, respectively.

Figure 2. Cell surviving fractions of CK-160 and TS-415 tumors irradiated with 10 Gy under air-breathing (○) or hypoxic (•) conditions. Points and horizontal lines represent individual tumors and mean values, respectively.

Both the CK-160 tumors and the TS-415 tumors differed significantly in HFRad, IFP, and pHe (). HFRad differed from 19 to 65% with a geometric mean of 41% and an arithmetic mean of 43% (CK-160) and from 8.4 to 40% with a geometric mean of 21% and an arithmetic mean of 24% (TS-415). IFP differed from 2.7 to 40 mmHg with a mean value of 19 mmHg (CK-160) and from 2.4 to 59 mmHg with a mean value of 24 mmHg (TS-415), and pHe differed from 6.2 to 7.3 with a mean value of 6.8 (CK-160) and from 5.9 to 7.3 with a mean value of 6.7 (TS-415). HFRad was significantly higher in the CK-160 tumors than in the TS-415 tumors (p = 0.000084; a), whereas the CK-160 and the TS-415 tumors did not differ significantly in IFP (p > 0.05; b) or pHe (p > 0.05; c).

Figure 3. HFRad (a), IFP (b), and pHe (c) of CK-160 and TS-415 tumors. Points and horizontal lines represent individual tumors and mean values, respectively.

Figure 3. HFRad (a), IFP (b), and pHe (c) of CK-160 and TS-415 tumors. Points and horizontal lines represent individual tumors and mean values, respectively.

The three pathophysiological parameters were not correlated with each other in any of the tumor lines. This is illustrated in , which shows plots of HFRad versus IFP, HFRad versus pHe, and IFP versus pHe for the CK-160 tumors (p > 0.05; Figure 4a) and the TS-415 tumors (p > 0.05; Figure 4b).

Figure 4. HFRad versus IFP, HFRad versus pHe, and IFP versus pHe for CK-160 (a) and TS-415 (b) tumors. Points represent individual tumors.

Figure 4. HFRad versus IFP, HFRad versus pHe, and IFP versus pHe for CK-160 (a) and TS-415 (b) tumors. Points represent individual tumors.

Twelve of the 22 mice bearing CK-160 tumors and eight of the 16 mice bearing TS-415 tumors developed lymph node metastases. In the CK-160 line (a), HFRad was ∼1.5-fold higher in the metastatic than in the nonmetastatic tumors (p = 0.0092), whereas the metastatic and nonmetastatic tumors did not differ significantly in IFP (p > 0.05) or pHe (p > 0.05). In the TS-415 line (b), IFP was∼ 2.6-fold higher in the tumors that metastasized than in those that did not metastasize (p = 0.0063), whereas the tumors of the metastasis-positive and metastasis-negative mice did not differ significantly in HFRad (p > 0.05) or pHe (p > 0.05).

Figure 5. HFRad, IFP, and pHe of metastatic and nonmetastatic CK-160 (a) and TS-415 (b) tumors. Points and horizontal lines represent individual tumors and mean values, respectively.

Figure 5. HFRad, IFP, and pHe of metastatic and nonmetastatic CK-160 (a) and TS-415 (b) tumors. Points and horizontal lines represent individual tumors and mean values, respectively.

Discussion

The disease-free and overall survival rates of patients with advanced squamous cell carcinoma of the uterine cervix have been shown to be associated with abnormalities in the physiological microenvironment of the primary tumor [Citation3–18]. The possibility that an abnormal physiological microenvironment may facilitate the development of lymph node metastases was investigated in the present preclinical study. Two cervical carcinoma xenograft lines were included in the study, and it has been shown that the tumors of these lines reflect the donor patients’ tumors in several biological properties, including histological appearance, radiation sensitivity and metastatic propensity [Citation19].

Preclinical studies are suitable for studying tumor-specific mechanisms of microenvironment-associated metastasis because large numbers of genetically equal tumors can be produced and included in experiments. A prerequisite is, however, that the individual tumors show highly different microenvironments. This condition was fulfilled for both tumor lines included in our study. The large physiological differences among the individual tumors were most likely a consequence of stochastic processes influencing the initiation of angiogenesis shortly after tumor cell inoculation. The intertumor heterogeneities in HFRad, IFP, and pHe of the CK-160 and the TS-415 lines were similar to those in comparable physiological parameters reported for cervical carcinomas in humans [Citation4,Citation7,Citation15].

Tumor hypoxia is a result of an imbalance between the rate of oxygen supply, determined primarily by the blood perfusion, and the rate of oxygen consumption, determined primarily by the respiratory activity of the tumor cells [Citation25]. Interstitial hypertension in tumors is mainly a consequence of high geometric and viscous resistance to blood flow, low resistance to transcapillary fluid flow, and impaired lymphatic drainage [Citation7,Citation16,Citation17]. Tumor acidity is primarily due to increased anaerobic metabolism, high rate of aerobic glycolysis, and insufficient vascular transport of acid and waste products [Citation26]. Thus, tumor hypoxia, interstitial hypertension, and acidity are partly consequences of microvascular abnormalities and partly consequences of vascular-unrelated tumor abnormalities [Citation4]. It has therefore been suggested that the fraction of hypoxic cells, IFP, and pHe might be closely related pathophysiological parameters in tumor tissue. However, there was no correlation between HFRad and IFP, HFRad and pHe, or IFP and pHe in any of the tumor lines in this study, implying that these parameters are not governed by a common mechanism in CK-160 or TS-415 tumors. This observation is consistent with the clinical observation that tissue pO2 is not correlated to IFP in cervical carcinomas [Citation7].

The development of lymph node metastases was found to be associated with the fraction of hypoxic cells in CK-160 tumors and with the level of interstitial hypertension in TS-415 tumors, whereas associations between lymph node metastasis and tumor acidity could not be detected in any of the tumor lines. These observations suggest that abnormalities in the physiological microenvironment of cervical carcinomas may facilitate metastatic dissemination and, furthermore, that different mechanisms may be involved in different tumors, depending on the biological properties of the tumor tissue. Interestingly, the CK-160 tumors were well differentiated (histological Grade I), whereas the TS-415 tumors were poorly differentiated (histological Grade III).

Tumor hypoxia may promote metastatic spread by inducing genomic instability and selecting for hypoxia-resistant, aggressive cell phenotypes [Citation9,Citation11]. However, this process is slow and is therefore not a probable mechanism for rapidly growing experimental tumors like the CK-160 tumors. Furthermore, studies in our laboratory have shown that long-term culturing of CK-160 cells under chronic or cycling (acute) hypoxia in vitro does not induce or select for cell variants with enhanced aggressiveness or increased metastatic potential.

It is far more probable that hypoxia facilitated lymph node metastasis of CK-160 tumors by up-regulating the expression of genes involved in the metastatic process [Citation9–11]. Tumor hypoxia activates several transcription factors including hypoxia-inducible factor-1 (HIF-1), and targets of HIF-1 play critical roles in many steps of the metastatic process, including angiogenesis, cell viability/apoptosis, cell proliferation/growth arrest, tissue remodelling/cell invasion, and glycolysis/metabolism [Citation27,Citation28]. The disease-free survival of cervical cancer patients has been shown to be associated with the expression of HIF-1 [Citation29–31] and several HIF-1 target genes, including the facilitative glucose transporter Glut-1 [Citation32] and the proangiogenic factor vascular endothelial growth factor-A (VEGF-A) [Citation33].

The development of lymph node metastases in TS-415 tumors was associated with the level of interstitial hypertension rather than the extent of hypoxia. Associations between IFP and metastasis have also been observed in nonhypoxic human melanoma xenografts [Citation34], and IFP has been shown to have independent prognostic power for relapse at distant sites in patients with cervical cancer [Citation16]. Mechanisms linking high IFP to increased metastasis have not been clearly identified, but possible mechanisms have been suggested. Thus, the outward fluid flow in the periphery of tumors with high IFP may be sufficiently strong to promote migration of tumor cells toward functional lymphatics surrounding the tumor tissue [Citation34]. Furthermore, the VEGF family of ligands may be up-regulated by interstitial hypertension and hence promote lymphangiogenesis and lymphatic intravasation in the tumor periphery [Citation35].

Tumor acidity may promote metastasis by up-regulating the expression of proteolytic enzymes as well as proangiogenic factors [Citation36,Citation37]. However, the development of lymph node metastases in CK-160 or TS-415 tumors was not associated with pHe despite the large intertumor heterogeneities in this parameter, possibly because any acidity-induced gene up-regulation was not sufficiently strong to influence the metastatic process significantly.

Our study shows unequivocally that lymph node metastasis in cervical carcinoma xenografts is associated with abnormalities in the physiological microenvironment of the primary tumor. It is thus conceivable that the poor survival rates of cervical cancer patients having developed primary tumors with severe microenvironmental abnormalities may be a consequence of microenvironment-induced metastasis and, hence, that the tumor microenvironment may represent an important target for novel therapeutic strategies in cervical carcinoma. Therapeutic strategies making use of antiangiogenic agents that normalize the tumor microvasculature may be particularly interesting because it has been shown that such agents may decrease tumor IFP as well as improve tumor oxygenation [Citation38]. Preclinical studies investigating this possibility in cervical carcinoma xenografts are highly warranted.

Acknowledgements

Financial support was received from the Norwegian Cancer Society and the South-Eastern Norway Regional Health Authority.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

  • Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol 2009;36:155–69.
  • Harry VN, Gilhert FJ, Parkin DE. Predicting the response of advanced cervical and ovarian tumors to therapy. Obstet Gynecol Surv 2009;64:548–60.
  • Vaupel P, Mayer A. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26:225 − 39.
  • Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449 − 65.
  • Vordermark D, Brown JM. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance. Strahlenther Onkol 2003;179:801 − 11.
  • Höckel M, Schlenger K, Knoop C, Vaupel P. Oxygenation of carcinomas of the uterine cervix: Evaluation by computerized O2 tension measurements. Cancer Res 1991;51:6098–102.
  • Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L, . Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 2001;61:6400–5.
  • Schwickert G, Walenta S, Sundfør K, Rofstad EK, Mueller-Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 1995;55: 4757–9.
  • Rofstad EK. Microenvironment-induced cancer metastasis. Int J Radiat Biol 2000;76:589–605.
  • Höckel M, Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266–76.
  • Subarsky P, Hill RP. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 2003;20: 237–50.
  • Höckel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, . Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45–50.
  • Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509–15.
  • Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, . Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149–56.
  • Sundfør K, Lyng H, Tropé CG, Rofstad EK. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 2000;54:101–7.
  • Fyles A, Milosevic M, Pintilie M, Syed A, Levin W, Manchul L, . Long-term performance of interstitial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol 2006;80:132–7.
  • Yeo SG, Kim JS, Cho MJ, Kim KH, Kim JS. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy. Clin Cancer Res 2009;15:6201–7.
  • Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfør K, Rofstad EK, . High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000;60:916–21.
  • Ellingsen C, Natvig I, Gaustad JV, Gulliksrud K, Egeland TAM, Rofstad EK. Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors. J Cancer Res Clin Oncol 2009;135:1177–84.
  • Ozerdem U, Hargens AR. A simple method for measuring interstitial fluid pressure in cancer tissues. Microvasc Res 2005;70:116–20.
  • Rofstad EK, Måseide K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours. Int J Radiat Biol 1999;75:1377–93.
  • Rofstad EK, Galappathi K, Mathiesen B, Ruud EBM. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res 2007;13:1971–8.
  • Ellingsen C, Egeland TAM, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009;73:838–45.
  • Hall EJ. Radiobiology for the radiologist. Philadelphia: Lippincott Wiliams & Wilkins; 2000. pp. 91–111.
  • Gulledge CJ, Dewhirst MW. Tumor oxygenation: A matter of supply and demand. Anticancer Res 1996;16:741 − 50.
  • Stubbs M, McSheehy PMJ, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000;6:15–9.
  • Harris AL. Hypoxia—a key regulatory factor in tumour growth. Nature Rev Cancer 2002;2:38–47.
  • Chan DA, Giaccia A. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 2007;26:333–9.
  • Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60:4693–6.
  • Burri P, Djonov V, Aebersold DM, Lindel K, Studer U, Altermatt HJ, . Significant correlation of hypoxia-inducible factor-1α with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:494–501.
  • Ishikawa H, Sakurai H, Hasegawa M, Mitsuhashi N, Takahashi M, Masuda N, . Expression of hypoxic-inducible factor 1α predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004;60:513–21.
  • Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, . Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 2001;7:928–34.
  • Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CML. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer 2000;83:620–5.
  • Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsør EF, Nilsen K, . Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res 2002;62: 661–4.
  • Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL, Pytowski B, . Imaging steps of lymphatic metastasis reveal that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: Therapeutic implications. Cancer Res 2006;66:8065–75.
  • Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006; 66:6699–707.
  • Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu L, Sloane BF, . Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009;69: 2260–8.
  • Jain RK. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005;307: 58–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.